82 related articles for article (PubMed ID: 32972432)
1. Unveiling the intriguing grape-like mass: Uterine cervical adenosarcoma.
Limaiem F; Ben Aissia N
Clin Case Rep; 2024 Mar; 12(3):e8683. PubMed ID: 38523826
[TBL] [Abstract][Full Text] [Related]
2. Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis.
Ngo C; Cotteret S; Deneche I; Kfoury M; Chehab R; Tran-Dien A; Vibert J; Leary A; Gouy S; Maulard A; Morice P; Scoazec JY; Pautier P; Genestie C
Hum Pathol; 2024 Apr; 148():14-22. PubMed ID: 38688412
[TBL] [Abstract][Full Text] [Related]
3. Case report: An atypical case of uterine adenosarcoma with extensive bizarre stromal cells and amplification of MDM2.
Xiao X; He Y
Front Oncol; 2024; 14():1351646. PubMed ID: 38549925
[TBL] [Abstract][Full Text] [Related]
4. Whole-Genome Sequencing and Target Validation Analysis of Müllerian Adenosarcoma: A Tumor With Complex but Specific Genetic Alterations.
Ban Y; Fischer JV; Maniar KP; Guo H; Zeng C; Li Y; Zhang Q; Wang X; Zhang W; Bulun SE; Wei JJ
Front Oncol; 2020; 10():538. PubMed ID: 32351899
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, treatment and survival of uterine sarcoma: A retrospective cohort study of 122 cases.
Plentz TBSF; Candido EC; Dias LF; Toledo MCS; Vale DB; Teixeira JC
Mol Clin Oncol; 2020 Dec; 13(6):81. PubMed ID: 33093955
[TBL] [Abstract][Full Text] [Related]
6. [Uterine adenosarcoma. Report of 5 cases and review of literature].
Barinova IV; Voloshchuk IN; Fedorov AA; Puchkova NV; Buyanova SN; Chechneva MA; Popov AA; Kapitanova OV; Kondrikov NI
Arkh Patol; 2021; 83(3):25-32. PubMed ID: 33822551
[TBL] [Abstract][Full Text] [Related]
7. Next-Generation Sequencing Analysis of 3 Uterine Adenosarcomas with Heterogeneously Differentiated Genomic Mutations.
Li Y; Meng X; Luo Y; Huang X; Luo S; Wang J
Int J Anal Chem; 2023; 2023():7436368. PubMed ID: 37810911
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite Instability Status and the Expression of p16 and Cyclin D1 Proteins in Uterine Adenosarcoma and Their Clinicopathological Significance.
Atilgan AO; Akcay EY; Ozen O; Haberal Reyhan AN; Ayhan A
Turk Patoloji Derg; 2023; 39(1):31-41. PubMed ID: 35876683
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Uterine Adenosarcoma With Sarcomatous Overgrowth and Malignant Heterologous Elements.
García-Mendoza YI; Murguia-Perez M; Galván-Linares AI; Mendoza-Ramírez S; García-Salinas NL; Moctezuma-Ramírez JG; Murillo-Ortiz BO; Bueno-Rosario LJ; Olvera-Olvera MA; Corredor-Alonso GE
Front Med (Lausanne); 2021; 8():819141. PubMed ID: 35083260
[TBL] [Abstract][Full Text] [Related]
10. Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.
Ashley CW; Da Cruz Paula A; Ferrando L; Gularte-Mérida R; Sebastiao APM; Brown DN; Gazzo AM; Pareja F; Stylianou A; Abu-Rustum NR; Reis-Filho JS; Buehler D; Weisman P; Chiang S; Weigelt B
Histopathology; 2021 Aug; 79(2):176-186. PubMed ID: 33527450
[TBL] [Abstract][Full Text] [Related]
11. BCOR Expression in Mullerian Adenosarcoma: A Potential Diagnostic Pitfall.
Muthukumarana V; Fix DJ; Stolnicu S; Park KJ; Soslow RA; Benayed R; Ladanyi M; Antonescu CR; Chiang S
Am J Surg Pathol; 2020 Jun; 44(6):765-770. PubMed ID: 32011345
[TBL] [Abstract][Full Text] [Related]
12. Uterine Adenosarcoma.
Ulrich UA; Denschlag D
Oncol Res Treat; 2018; 41(11):693-696. PubMed ID: 30326467
[TBL] [Abstract][Full Text] [Related]
13. Mullerian adenosarcoma (heterologous) of uterine cervix with sarcomatous overgrowth: A case report with review of the literature.
Mohapatra D; Mohanty P; Biswal R
Indian J Pathol Microbiol; 2019; 62(1):139-141. PubMed ID: 30706880
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.
Omi M; Tonooka A; Chiba T; Tanaka Y; Fusegi A; Aoki Y; Nomura H; Kanao H; Takazawa Y
Diagn Pathol; 2020 Sep; 15(1):119. PubMed ID: 32972432
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
Amant F; Schurmans K; Steenkiste E; Verbist L; Abeler VM; Tulunay G; De Jonge E; Massuger L; Moerman P; Vergote I
Gynecol Oncol; 2004 Jun; 93(3):680-5. PubMed ID: 15196864
[TBL] [Abstract][Full Text] [Related]
16. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
